Simcere Pharmaceutical Group Limited
HKSE: 2096.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yunshu Zhou
- Employees
- 6,584
- Headquarters
- Nanjing, China
- IPO year
- 2020
- Market cap
- HK$31.0B
- Website
- https://www.simcere.com
Loading 2096…
Loading profile data…Frequently asked questions about 2096
What does Simcere Pharmaceutical Group Limited (2096.HK) do?
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and oth...
Where does 2096.HK trade?
Simcere Pharmaceutical Group Limited (2096.HK) trades on the Hong Kong Stock Exchange.
What sector is 2096.HK in?
Simcere Pharmaceutical Group Limited (2096.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Simcere Pharmaceutical Group Limited?
Yunshu Zhou is the chief executive officer of Simcere Pharmaceutical Group Limited (2096.HK).
Where is Simcere Pharmaceutical Group Limited headquartered?
Simcere Pharmaceutical Group Limited is headquartered in China.
Does 2096.HK pay a dividend?
Yes — Simcere Pharmaceutical Group Limited (2096.HK) paid a trailing twelve-month dividend of HKD 0.17 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2096.HK go public?
Simcere Pharmaceutical Group Limited (2096.HK) completed its initial public offering in 2020.